美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
38878 A II 2023/09/27 HUZHOU ZHANWANG PHARMACEUTICAL CO LTD LEUCOVORIN CALCIUM
38904 A II 2023/09/27 HYBIO PHARMACEUTICAL CO LTD DEGARELIX ACETATE, NON-STERILE DRUG SUBSTANCE
38905 A II 2023/09/27 ZHEJIANG HONGYUAN PHARMACEUTICAL CO LTD EMPAGLIFLOZIN ADVANCED INTERMIDIATE (EP2)
38914 A II 2023/09/27 GUANGDONG RAFFLES PHARMATECH CO LTD ELTROMBOPAG OLAMINE
38953 A IV 2023/09/27 MLA INDUSTRIES PVT LTD MAGNESIUM STEARATE USP/BP/EP/IP/JP
38958 A II 2023/09/27 CHANGZHOU PHARMACEUTICAL FACTORY AGOMELATINE
38960 A II 2023/09/27 MACSEN DRUGS FLUORESCEIN SODIUM USP
37008 A II 2023/09/27 LEK PHARMACEUTICALS DD POTASSIUM CLAVULANATE DILUTED WITH SILICON DIOXIDE IN THE RATIO 1:1
38651 A II 2023/09/27 JIANGSU GENSCRIPT BIOTECH CO LTD GMP SINGLE-GUIDE RNA MANUFACTURING
38733 A II 2023/09/27 GLAND PHARMA LTD EPINEPHRINE (LOW EPIMER)
38734 A II 2023/09/27 JIANGXI SYNERGY PHARMACEUTICAL CO LTD CANAGLIFLOZIN HEMIHYDRATE
38791 A II 2023/09/27 HUNAN WARRANT CHIRAL PHARMACEUTICAL CO LTD PANTOPRAZOLE SODIUM
38797 A II 2023/09/27 MYLAN LABORATORIES LTD SELEGILINE
38849 A II 2023/09/26 ZHUHAI BIORI BIOTECHNOLOGY CO LTD RIBONUCLEASE R (GMP GRADE)
38850 A II 2023/09/26 ZHUHAI BIORI BIOTECHNOLOGY CO LTD T7 RNA POLYMERASE (GMP GRADE)
38858 A II 2023/09/26 EDMOND PHARMA SRL LEVOBUPIVACAINE HYDROCHLORIDE
38912 A II 2023/09/26 FARMAK AS TAFAMIDIS MEGLUMINE (NON-MICRONIZED)
38919 A II 2023/09/26 WISDOM PHARMACEUTICAL CO LTD IBRUTINIB
38933 A II 2023/09/26 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD CARIPRAZINE HYDROCHLORIDE
38523 A II 2023/09/26 MACLEODS PHARMACEUTICALS LTD TOFACITINIB CITRATE

数据库说明:

当前数据更新日期:2023年11月(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2024 DrugFuture->U.S. FDA Drug Master Files